# An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers

> **NCT01050309** · PHASE1 · COMPLETED · sponsor: **Photocure** · enrollment: 8 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** hexaminolevulinate (HAL)

## Key facts

- **NCT ID:** NCT01050309
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050309, "An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01050309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*